Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.

Standard

Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. / Capitanio, Umberto; Ahyai, Sascha; Graefen, Markus; Jeldres, Claudio; Shariat, Shahrokh F; Erbersdobler, Andreas; Schlomm, Thorsten; Haese, Alexander; Steuber, Thomas; Heinzer, Hans; Perrotte, Paul; Péloquin, François; Pharand, Daniel; Arjane, Philippe; Huland, Hartwig; Karakiewicz, Pierre I.

In: UROLOGY, Vol. 72, No. 6, 6, 2008, p. 1203-1208.

Research output: SCORING: Contribution to journalSCORING: Journal articleResearchpeer-review

Harvard

Capitanio, U, Ahyai, S, Graefen, M, Jeldres, C, Shariat, SF, Erbersdobler, A, Schlomm, T, Haese, A, Steuber, T, Heinzer, H, Perrotte, P, Péloquin, F, Pharand, D, Arjane, P, Huland, H & Karakiewicz, PI 2008, 'Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.', UROLOGY, vol. 72, no. 6, 6, pp. 1203-1208. <http://www.ncbi.nlm.nih.gov/pubmed/18692880?dopt=Citation>

APA

Capitanio, U., Ahyai, S., Graefen, M., Jeldres, C., Shariat, S. F., Erbersdobler, A., Schlomm, T., Haese, A., Steuber, T., Heinzer, H., Perrotte, P., Péloquin, F., Pharand, D., Arjane, P., Huland, H., & Karakiewicz, P. I. (2008). Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. UROLOGY, 72(6), 1203-1208. [6]. http://www.ncbi.nlm.nih.gov/pubmed/18692880?dopt=Citation

Vancouver

Capitanio U, Ahyai S, Graefen M, Jeldres C, Shariat SF, Erbersdobler A et al. Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer. UROLOGY. 2008;72(6):1203-1208. 6.

Bibtex

@article{e69b25392cb64b16baaed48e73af30b3,
title = "Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.",
abstract = "OBJECTIVES: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). METHODS: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume",
author = "Umberto Capitanio and Sascha Ahyai and Markus Graefen and Claudio Jeldres and Shariat, {Shahrokh F} and Andreas Erbersdobler and Thorsten Schlomm and Alexander Haese and Thomas Steuber and Hans Heinzer and Paul Perrotte and Fran{\c c}ois P{\'e}loquin and Daniel Pharand and Philippe Arjane and Hartwig Huland and Karakiewicz, {Pierre I}",
year = "2008",
language = "Deutsch",
volume = "72",
pages = "1203--1208",
journal = "UROLOGY",
issn = "0090-4295",
publisher = "Elsevier Inc.",
number = "6",

}

RIS

TY - JOUR

T1 - Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.

AU - Capitanio, Umberto

AU - Ahyai, Sascha

AU - Graefen, Markus

AU - Jeldres, Claudio

AU - Shariat, Shahrokh F

AU - Erbersdobler, Andreas

AU - Schlomm, Thorsten

AU - Haese, Alexander

AU - Steuber, Thomas

AU - Heinzer, Hans

AU - Perrotte, Paul

AU - Péloquin, François

AU - Pharand, Daniel

AU - Arjane, Philippe

AU - Huland, Hartwig

AU - Karakiewicz, Pierre I

PY - 2008

Y1 - 2008

N2 - OBJECTIVES: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). METHODS: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume

AB - OBJECTIVES: To examine the rate of biochemical recurrence (BCR) in patients with pathologically confirmed insignificant prostate cancer (PIPCa). METHODS: A total of 1358 patients underwent open retropubic radical prostatectomy at the University Medical Center Eppendorf in Hamburg, Germany, and their specimens were whole-mounted, step-sectioned, and subjected to computer-based three-dimensional reconstruction. We identified patients who fulfilled the Epstein criteria for definition of PIPCa (tumor volume

M3 - SCORING: Zeitschriftenaufsatz

VL - 72

SP - 1203

EP - 1208

JO - UROLOGY

JF - UROLOGY

SN - 0090-4295

IS - 6

M1 - 6

ER -